CAS Medical Systems, Inc.
CASM
CASM was delisted on the 18th of April, 2019.
0 hedge funds and large institutions have $0 invested in CAS Medical Systems, Inc. in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 32 closing their positions.
100% less funds holding
Funds holding: 32 → 0 (-32)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $21.7M → $0 (-$21.7M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 32
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$12.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.02M |
| 3 |
Renaissance Technologies
New York
|
-$1.65M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$1.16M |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
-$713K |
CASM Hedge Fund Activity: Q2 2019 in Review
0 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in CAS Medical Systems, Inc. (CASM) for Q2 2019, worth a combined $0 — down 100% from $21.7M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of CASM and 0 opened new positions — a net loss of 32 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Acuta Capital Partners, exiting entirely with an estimated $12.8M sold.
- 0 institutional investors held CAS Medical Systems, Inc. (CASM) as of Q2 2019, down from 32 in Q1 2019.
- Funds reported $0 of CAS Medical Systems, Inc. stock for Q2 2019, down 100% quarter-over-quarter.
- 0 funds opened new CAS Medical Systems, Inc. positions in Q2 2019 and 32 closed out, a net change of -32 holders.
- The largest CAS Medical Systems, Inc. seller in Q2 2019 was Acuta Capital Partners, an estimated $12.8M sold.
Based on aggregated 13F filings for Q2 2019.